

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GDP-mannose metabolic process (GO:0019673) | 6.07879084 |
| 2 | regulation of skeletal muscle contraction (GO:0014819) | 4.36223219 |
| 3 | glycosphingolipid catabolic process (GO:0046479) | 3.95124481 |
| 4 | mannose metabolic process (GO:0006013) | 3.94790882 |
| 5 | oligosaccharide catabolic process (GO:0009313) | 3.93121189 |
| 6 | cellular response to ATP (GO:0071318) | 3.84071511 |
| 7 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.71756398 |
| 8 | adenosine receptor signaling pathway (GO:0001973) | 3.60311618 |
| 9 | glycolipid catabolic process (GO:0019377) | 3.58992013 |
| 10 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.53326156 |
| 11 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.53326156 |
| 12 | nucleotide salvage (GO:0043173) | 3.49846384 |
| 13 | glutathione biosynthetic process (GO:0006750) | 3.37858502 |
| 14 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.30699780 |
| 15 | sphingolipid catabolic process (GO:0030149) | 3.22099296 |
| 16 | sulfur amino acid catabolic process (GO:0000098) | 3.22028154 |
| 17 | response to peptidoglycan (GO:0032494) | 3.14376157 |
| 18 | membrane lipid catabolic process (GO:0046466) | 3.12707799 |
| 19 | UV protection (GO:0009650) | 3.11181667 |
| 20 | rRNA modification (GO:0000154) | 3.08014106 |
| 21 | ceramide catabolic process (GO:0046514) | 3.06937412 |
| 22 | positive regulation of heat generation (GO:0031652) | 3.06101622 |
| 23 | phosphatidylglycerol biosynthetic process (GO:0006655) | 3.05535395 |
| 24 | positive regulation of protein kinase C signaling (GO:0090037) | 3.04247821 |
| 25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.02972075 |
| 26 | protein carboxylation (GO:0018214) | 3.02972075 |
| 27 | proline biosynthetic process (GO:0006561) | 3.02384324 |
| 28 | NIK/NF-kappaB signaling (GO:0038061) | 3.00588178 |
| 29 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.98938374 |
| 30 | amino sugar catabolic process (GO:0046348) | 2.97568227 |
| 31 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.91216009 |
| 32 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.90572563 |
| 33 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.89713047 |
| 34 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.89173176 |
| 35 | creatine metabolic process (GO:0006600) | 2.88578584 |
| 36 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.86896588 |
| 37 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.85384456 |
| 38 | NADH metabolic process (GO:0006734) | 2.84564180 |
| 39 | rRNA methylation (GO:0031167) | 2.83947053 |
| 40 | purine nucleotide salvage (GO:0032261) | 2.81296913 |
| 41 | response to thyroid hormone (GO:0097066) | 2.80994320 |
| 42 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.79006376 |
| 43 | response to ATP (GO:0033198) | 2.78807440 |
| 44 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.77860610 |
| 45 | pyrimidine nucleoside salvage (GO:0043097) | 2.76677865 |
| 46 | pyrimidine-containing compound salvage (GO:0008655) | 2.76677865 |
| 47 | cellular response to arsenic-containing substance (GO:0071243) | 2.73575029 |
| 48 | low-density lipoprotein particle clearance (GO:0034383) | 2.72249165 |
| 49 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.71918432 |
| 50 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.69407676 |
| 51 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.69289097 |
| 52 | N-acetylneuraminate metabolic process (GO:0006054) | 2.67519220 |
| 53 | protein insertion into membrane (GO:0051205) | 2.67500768 |
| 54 | regulation of cholesterol storage (GO:0010885) | 2.66476714 |
| 55 | proline metabolic process (GO:0006560) | 2.65486552 |
| 56 | nucleoside transmembrane transport (GO:1901642) | 2.64368301 |
| 57 | urea cycle (GO:0000050) | 2.62335303 |
| 58 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.62278693 |
| 59 | purinergic receptor signaling pathway (GO:0035587) | 2.60583632 |
| 60 | purine ribonucleotide transport (GO:0015868) | 2.58258333 |
| 61 | sphingosine metabolic process (GO:0006670) | 2.56379545 |
| 62 | tRNA modification (GO:0006400) | 2.55684364 |
| 63 | positive regulation of prostaglandin secretion (GO:0032308) | 2.55153473 |
| 64 | activation of MAPKKK activity (GO:0000185) | 2.54578262 |
| 65 | folic acid metabolic process (GO:0046655) | 2.53681848 |
| 66 | metallo-sulfur cluster assembly (GO:0031163) | 2.53575841 |
| 67 | iron-sulfur cluster assembly (GO:0016226) | 2.53575841 |
| 68 | adenine nucleotide transport (GO:0051503) | 2.53308309 |
| 69 | urea metabolic process (GO:0019627) | 2.53154566 |
| 70 | oxaloacetate metabolic process (GO:0006107) | 2.52259739 |
| 71 | NAD biosynthetic process (GO:0009435) | 2.51815930 |
| 72 | cytochrome complex assembly (GO:0017004) | 2.51603114 |
| 73 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.51213032 |
| 74 | L-phenylalanine metabolic process (GO:0006558) | 2.51213032 |
| 75 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.51179277 |
| 76 | respiratory chain complex IV assembly (GO:0008535) | 2.49276239 |
| 77 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.49037405 |
| 78 | glutathione metabolic process (GO:0006749) | 2.47989317 |
| 79 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.41142441 |
| 80 | transepithelial transport (GO:0070633) | 2.40491640 |
| 81 | quinone biosynthetic process (GO:1901663) | 2.40318161 |
| 82 | cellular metabolic compound salvage (GO:0043094) | 2.39319958 |
| 83 | deoxyribonucleotide catabolic process (GO:0009264) | 2.38972459 |
| 84 | folic acid transport (GO:0015884) | 2.38740531 |
| 85 | pseudouridine synthesis (GO:0001522) | 2.37960946 |
| 86 | regulation of cholesterol metabolic process (GO:0090181) | 2.37445404 |
| 87 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.36496583 |
| 88 | diol metabolic process (GO:0034311) | 2.36409061 |
| 89 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.35399199 |
| 90 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.35118869 |
| 91 | mitochondrial genome maintenance (GO:0000002) | 2.34894567 |
| 92 | base-excision repair, AP site formation (GO:0006285) | 2.33208482 |
| 93 | nitrogen cycle metabolic process (GO:0071941) | 2.33054152 |
| 94 | regulation of vitamin metabolic process (GO:0030656) | 2.32894112 |
| 95 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 2.32338497 |
| 96 | positive regulation of systemic arterial blood pressure (GO:0003084) | 2.32119200 |
| 97 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.31497226 |
| 98 | plasma lipoprotein particle clearance (GO:0034381) | 2.30709105 |
| 99 | oxidative phosphorylation (GO:0006119) | 2.30357341 |
| 100 | peptide biosynthetic process (GO:0043043) | 2.30057437 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.61482055 |
| 2 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.91771311 |
| 3 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.68707736 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.64554926 |
| 5 | P68_20966046_ChIP-Seq_HELA_Human | 2.36858734 |
| 6 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.34242456 |
| 7 | MYC_22102868_ChIP-Seq_BL_Human | 2.12871961 |
| 8 | BCL6_27268052_Chip-Seq_Bcells_Human | 2.04836727 |
| 9 | BCOR_27268052_Chip-Seq_Bcells_Human | 2.04278387 |
| 10 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.03660736 |
| 11 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 2.01345468 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.95937709 |
| 13 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.92850513 |
| 14 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.86961788 |
| 15 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.86414104 |
| 16 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.85154286 |
| 17 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.83923286 |
| 18 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.83054304 |
| 19 | MAF_26560356_Chip-Seq_TH2_Human | 1.79740013 |
| 20 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.77907164 |
| 21 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.75105142 |
| 22 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.70421175 |
| 23 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.69808230 |
| 24 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.69737718 |
| 25 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.69156274 |
| 26 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.66966727 |
| 27 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.66382688 |
| 28 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.65562165 |
| 29 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.65052772 |
| 30 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.64570386 |
| 31 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.64538322 |
| 32 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.63735914 |
| 33 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.62457870 |
| 34 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.59902716 |
| 35 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.58763144 |
| 36 | MAF_26560356_Chip-Seq_TH1_Human | 1.57625361 |
| 37 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.55787396 |
| 38 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.55164597 |
| 39 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.54206886 |
| 40 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.51140108 |
| 41 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.49182005 |
| 42 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.49109865 |
| 43 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.45341104 |
| 44 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.45135469 |
| 45 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.44314920 |
| 46 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.42940482 |
| 47 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.41960350 |
| 48 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.41922110 |
| 49 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.41046657 |
| 50 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.40587398 |
| 51 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.38469202 |
| 52 | SA1_27219007_Chip-Seq_Bcells_Human | 1.38416928 |
| 53 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.38412683 |
| 54 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38297051 |
| 55 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.37480227 |
| 56 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.36106789 |
| 57 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.35394918 |
| 58 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.35109138 |
| 59 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.33911747 |
| 60 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.32307141 |
| 61 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.32161087 |
| 62 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32098411 |
| 63 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.30758140 |
| 64 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.30640140 |
| 65 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.29941828 |
| 66 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.29581471 |
| 67 | UTX_26944678_Chip-Seq_JUKART_Human | 1.29404863 |
| 68 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.26930331 |
| 69 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.25704462 |
| 70 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25019190 |
| 71 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.22880089 |
| 72 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.22520265 |
| 73 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22378940 |
| 74 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.22289443 |
| 75 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.20706694 |
| 76 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.20291950 |
| 77 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19840949 |
| 78 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.19799896 |
| 79 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18763367 |
| 80 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.17701881 |
| 81 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.16831419 |
| 82 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.15857184 |
| 83 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15719973 |
| 84 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.15532771 |
| 85 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.14840805 |
| 86 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.14695650 |
| 87 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.14320118 |
| 88 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.13613056 |
| 89 | P300_27268052_Chip-Seq_Bcells_Human | 1.13264839 |
| 90 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.13152840 |
| 91 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.13035180 |
| 92 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12880340 |
| 93 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.12182197 |
| 94 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.12055404 |
| 95 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.09816918 |
| 96 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.08853913 |
| 97 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.08333495 |
| 98 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.07862805 |
| 99 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.07794575 |
| 100 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.07569539 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 4.50788376 |
| 2 | MP0009840_abnormal_foam_cell | 3.94746878 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.80173425 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 3.65048904 |
| 5 | MP0005451_abnormal_body_composition | 3.15689732 |
| 6 | MP0003303_peritoneal_inflammation | 2.61147854 |
| 7 | MP0005365_abnormal_bile_salt | 2.37195709 |
| 8 | MP0001986_abnormal_taste_sensitivity | 2.28176437 |
| 9 | MP0008875_abnormal_xenobiotic_pharmacok | 2.25968225 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 2.14099514 |
| 11 | MP0003172_abnormal_lysosome_physiology | 2.12264677 |
| 12 | MP0006036_abnormal_mitochondrial_physio | 2.03414499 |
| 13 | MP0009278_abnormal_bone_marrow | 2.01996266 |
| 14 | MP0005083_abnormal_biliary_tract | 1.91375654 |
| 15 | MP0005360_urolithiasis | 1.88937038 |
| 16 | MP0001661_extended_life_span | 1.82636255 |
| 17 | MP0004510_myositis | 1.81779910 |
| 18 | MP0005174_abnormal_tail_pigmentation | 1.77658494 |
| 19 | MP0006082_CNS_inflammation | 1.76659153 |
| 20 | MP0002254_reproductive_system_inflammat | 1.75084103 |
| 21 | MP0001873_stomach_inflammation | 1.71479868 |
| 22 | MP0003436_decreased_susceptibility_to | 1.70444749 |
| 23 | MP0003453_abnormal_keratinocyte_physiol | 1.70328140 |
| 24 | MP0005330_cardiomyopathy | 1.69703805 |
| 25 | MP0000747_muscle_weakness | 1.61686883 |
| 26 | MP0000751_myopathy | 1.59681884 |
| 27 | MP0000750_abnormal_muscle_regeneration | 1.59511231 |
| 28 | MP0003646_muscle_fatigue | 1.58942250 |
| 29 | MP0005171_absent_coat_pigmentation | 1.58802464 |
| 30 | MP0009333_abnormal_splenocyte_physiolog | 1.57483041 |
| 31 | MP0005332_abnormal_amino_acid | 1.55329238 |
| 32 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.45878039 |
| 33 | MP0005025_abnormal_response_to | 1.42990542 |
| 34 | MP0005423_abnormal_somatic_nervous | 1.41681381 |
| 35 | MP0000604_amyloidosis | 1.39598170 |
| 36 | MP0003136_yellow_coat_color | 1.39356266 |
| 37 | MP0009785_altered_susceptibility_to | 1.34819110 |
| 38 | MP0005397_hematopoietic_system_phenotyp | 1.33949216 |
| 39 | MP0001545_abnormal_hematopoietic_system | 1.33949216 |
| 40 | MP0000343_altered_response_to | 1.32283192 |
| 41 | MP0008469_abnormal_protein_level | 1.32258720 |
| 42 | MP0002837_dystrophic_cardiac_calcinosis | 1.32007367 |
| 43 | MP0005387_immune_system_phenotype | 1.30722425 |
| 44 | MP0001790_abnormal_immune_system | 1.30722425 |
| 45 | MP0004019_abnormal_vitamin_homeostasis | 1.28135519 |
| 46 | MP0000685_abnormal_immune_system | 1.27355457 |
| 47 | MP0003075_altered_response_to | 1.25640363 |
| 48 | MP0009764_decreased_sensitivity_to | 1.25079091 |
| 49 | MP0002419_abnormal_innate_immunity | 1.24765445 |
| 50 | MP0001764_abnormal_homeostasis | 1.23838110 |
| 51 | MP0005000_abnormal_immune_tolerance | 1.22565096 |
| 52 | MP0001756_abnormal_urination | 1.21421252 |
| 53 | MP0009643_abnormal_urine_homeostasis | 1.19750870 |
| 54 | MP0003191_abnormal_cellular_cholesterol | 1.19104248 |
| 55 | MP0001835_abnormal_antigen_presentation | 1.17811151 |
| 56 | MP0010155_abnormal_intestine_physiology | 1.16522125 |
| 57 | MP0005670_abnormal_white_adipose | 1.16447099 |
| 58 | MP0002138_abnormal_hepatobiliary_system | 1.14787815 |
| 59 | MP0002723_abnormal_immune_serum | 1.14545701 |
| 60 | MP0000538_abnormal_urinary_bladder | 1.14088089 |
| 61 | MP0004130_abnormal_muscle_cell | 1.12966812 |
| 62 | MP0001845_abnormal_inflammatory_respons | 1.11911790 |
| 63 | MP0005085_abnormal_gallbladder_physiolo | 1.11195426 |
| 64 | MP0002452_abnormal_antigen_presenting | 1.08130331 |
| 65 | MP0005319_abnormal_enzyme/_coenzyme | 1.05291002 |
| 66 | MP0005410_abnormal_fertilization | 1.04916422 |
| 67 | MP0000003_abnormal_adipose_tissue | 1.04273669 |
| 68 | MP0002118_abnormal_lipid_homeostasis | 1.02818002 |
| 69 | MP0000015_abnormal_ear_pigmentation | 1.01708462 |
| 70 | MP0003879_abnormal_hair_cell | 1.01431571 |
| 71 | MP0004185_abnormal_adipocyte_glucose | 0.98740829 |
| 72 | MP0000609_abnormal_liver_physiology | 0.97198364 |
| 73 | MP0005666_abnormal_adipose_tissue | 0.96565647 |
| 74 | MP0005671_abnormal_response_to | 0.95918034 |
| 75 | MP0005375_adipose_tissue_phenotype | 0.95901872 |
| 76 | MP0002132_abnormal_respiratory_system | 0.95132130 |
| 77 | MP0003693_abnormal_embryo_hatching | 0.93798243 |
| 78 | MP0005166_decreased_susceptibility_to | 0.93724998 |
| 79 | MP0001800_abnormal_humoral_immune | 0.93096571 |
| 80 | MP0000678_abnormal_parathyroid_gland | 0.91582227 |
| 81 | MP0005310_abnormal_salivary_gland | 0.91247903 |
| 82 | MP0003329_amyloid_beta_deposits | 0.90455113 |
| 83 | MP0005167_abnormal_blood-brain_barrier | 0.89181134 |
| 84 | MP0003656_abnormal_erythrocyte_physiolo | 0.87791502 |
| 85 | MP0004947_skin_inflammation | 0.86178951 |
| 86 | MP0001819_abnormal_immune_cell | 0.86041119 |
| 87 | MP0002420_abnormal_adaptive_immunity | 0.85737326 |
| 88 | MP0005076_abnormal_cell_differentiation | 0.84690827 |
| 89 | MP0008260_abnormal_autophagy | 0.83995245 |
| 90 | MP0005636_abnormal_mineral_homeostasis | 0.83889832 |
| 91 | MP0004233_abnormal_muscle_weight | 0.81849860 |
| 92 | MP0004043_abnormal_pH_regulation | 0.81722054 |
| 93 | MP0001765_abnormal_ion_homeostasis | 0.80637147 |
| 94 | MP0003186_abnormal_redox_activity | 0.80495191 |
| 95 | MP0001663_abnormal_digestive_system | 0.80129162 |
| 96 | MP0003137_abnormal_impulse_conducting | 0.80078020 |
| 97 | MP0006035_abnormal_mitochondrial_morpho | 0.79896250 |
| 98 | MP0008874_decreased_physiological_sensi | 0.78565693 |
| 99 | MP0010329_abnormal_lipoprotein_level | 0.77906747 |
| 100 | MP0001968_abnormal_touch/_nociception | 0.75715836 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 4.64866609 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.64866609 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.64866609 |
| 4 | Testicular atrophy (HP:0000029) | 4.36247060 |
| 5 | Increased cerebral lipofuscin (HP:0011813) | 3.86100251 |
| 6 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.76210873 |
| 7 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.69000691 |
| 8 | Myopathic facies (HP:0002058) | 3.51580015 |
| 9 | Mesangial abnormality (HP:0001966) | 3.41160694 |
| 10 | Ragged-red muscle fibers (HP:0003200) | 3.31380768 |
| 11 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.25740591 |
| 12 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.25740591 |
| 13 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.25740591 |
| 14 | Dysostosis multiplex (HP:0000943) | 3.25464413 |
| 15 | Systemic lupus erythematosus (HP:0002725) | 3.25032325 |
| 16 | Vacuolated lymphocytes (HP:0001922) | 3.24963964 |
| 17 | Thin bony cortex (HP:0002753) | 3.24377893 |
| 18 | Increased muscle lipid content (HP:0009058) | 3.13472170 |
| 19 | Mucopolysacchariduria (HP:0008155) | 3.00983928 |
| 20 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.00983928 |
| 21 | Increased intramyocellular lipid droplets (HP:0012240) | 2.91678218 |
| 22 | Hemorrhage of the eye (HP:0011885) | 2.86130953 |
| 23 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.76755641 |
| 24 | Increased serum ferritin (HP:0003281) | 2.75932105 |
| 25 | Asymmetric septal hypertrophy (HP:0001670) | 2.66086439 |
| 26 | Progressive muscle weakness (HP:0003323) | 2.63231371 |
| 27 | Rib fusion (HP:0000902) | 2.53599151 |
| 28 | Prolonged partial thromboplastin time (HP:0003645) | 2.48515834 |
| 29 | Vaginal fistula (HP:0004320) | 2.48060959 |
| 30 | Exercise-induced myalgia (HP:0003738) | 2.47498721 |
| 31 | Renal Fanconi syndrome (HP:0001994) | 2.44345910 |
| 32 | Petechiae (HP:0000967) | 2.37110591 |
| 33 | Lipid accumulation in hepatocytes (HP:0006561) | 2.35362679 |
| 34 | Bulbar palsy (HP:0001283) | 2.35095613 |
| 35 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.34043739 |
| 36 | Dicarboxylic aciduria (HP:0003215) | 2.33428736 |
| 37 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.33428736 |
| 38 | Rhabdomyolysis (HP:0003201) | 2.30104439 |
| 39 | Malnutrition (HP:0004395) | 2.28250048 |
| 40 | Axonal loss (HP:0003447) | 2.28167121 |
| 41 | Loss of speech (HP:0002371) | 2.28004831 |
| 42 | Abnormality of the intrinsic pathway (HP:0010989) | 2.26479154 |
| 43 | Delayed epiphyseal ossification (HP:0002663) | 2.25528070 |
| 44 | Poikiloderma (HP:0001029) | 2.25167728 |
| 45 | Hepatocellular necrosis (HP:0001404) | 2.18634263 |
| 46 | Abnormality of iron homeostasis (HP:0011031) | 2.17966925 |
| 47 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.17883441 |
| 48 | Reduced antithrombin III activity (HP:0001976) | 2.15275443 |
| 49 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.15137324 |
| 50 | Akinesia (HP:0002304) | 2.14750085 |
| 51 | Attenuation of retinal blood vessels (HP:0007843) | 2.14482511 |
| 52 | Atrioventricular block (HP:0001678) | 2.13383357 |
| 53 | Rectal fistula (HP:0100590) | 2.13337223 |
| 54 | Rectovaginal fistula (HP:0000143) | 2.13337223 |
| 55 | Joint hemorrhage (HP:0005261) | 2.08362202 |
| 56 | Dyschromatopsia (HP:0007641) | 2.08046839 |
| 57 | Increased hepatocellular lipid droplets (HP:0006565) | 2.06821205 |
| 58 | Esophageal neoplasm (HP:0100751) | 2.04503784 |
| 59 | Neoplasm of head and neck (HP:0012288) | 2.04503784 |
| 60 | Prolonged neonatal jaundice (HP:0006579) | 2.04458112 |
| 61 | Intestinal fistula (HP:0100819) | 2.03981226 |
| 62 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.03467600 |
| 63 | Squamous cell carcinoma (HP:0002860) | 2.02973584 |
| 64 | Microvesicular hepatic steatosis (HP:0001414) | 2.02566710 |
| 65 | Hepatic necrosis (HP:0002605) | 2.01353626 |
| 66 | Joint stiffness (HP:0001387) | 1.99875639 |
| 67 | Abnormal atrioventricular conduction (HP:0005150) | 1.96004323 |
| 68 | Mitochondrial inheritance (HP:0001427) | 1.95990478 |
| 69 | Neonatal onset (HP:0003623) | 1.95834340 |
| 70 | Generalized aminoaciduria (HP:0002909) | 1.95139934 |
| 71 | Abnormality of the costochondral junction (HP:0000919) | 1.94392363 |
| 72 | Heart block (HP:0012722) | 1.92901739 |
| 73 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.92775055 |
| 74 | Complement deficiency (HP:0004431) | 1.91846107 |
| 75 | Purpura (HP:0000979) | 1.91083824 |
| 76 | Facial diplegia (HP:0001349) | 1.90477292 |
| 77 | Abnormality of macrophages (HP:0004311) | 1.88887816 |
| 78 | Annular pancreas (HP:0001734) | 1.88735865 |
| 79 | Glomerulonephritis (HP:0000099) | 1.88491505 |
| 80 | Nuclear cataract (HP:0100018) | 1.88249568 |
| 81 | Progressive external ophthalmoplegia (HP:0000590) | 1.88126334 |
| 82 | External ophthalmoplegia (HP:0000544) | 1.87643062 |
| 83 | Increased CSF lactate (HP:0002490) | 1.87261882 |
| 84 | Flat occiput (HP:0005469) | 1.86841556 |
| 85 | Xanthomatosis (HP:0000991) | 1.85596342 |
| 86 | Metaphyseal irregularity (HP:0003025) | 1.85536378 |
| 87 | Cholelithiasis (HP:0001081) | 1.85512380 |
| 88 | Fetal akinesia sequence (HP:0001989) | 1.85498088 |
| 89 | Abnormal trabecular bone morphology (HP:0100671) | 1.85285484 |
| 90 | Autoimmune thrombocytopenia (HP:0001973) | 1.84692685 |
| 91 | Turricephaly (HP:0000262) | 1.83898644 |
| 92 | Aplasia of the musculature (HP:0100854) | 1.83833175 |
| 93 | J-shaped sella turcica (HP:0002680) | 1.82889684 |
| 94 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.82481555 |
| 95 | Exercise intolerance (HP:0003546) | 1.81112648 |
| 96 | Ulnar bowing (HP:0003031) | 1.80567178 |
| 97 | Hypertensive crisis (HP:0100735) | 1.79274649 |
| 98 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.79139441 |
| 99 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.79000612 |
| 100 | Lactic acidosis (HP:0003128) | 1.78965468 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 5.04281708 |
| 2 | IRAK3 | 3.43397492 |
| 3 | ERN1 | 3.31196125 |
| 4 | TRIB3 | 3.15579137 |
| 5 | TLK1 | 2.99108413 |
| 6 | PDK2 | 2.78696701 |
| 7 | MAP3K11 | 2.62037086 |
| 8 | MAPK15 | 2.54630069 |
| 9 | PIM2 | 2.38905078 |
| 10 | TESK2 | 2.26847784 |
| 11 | MAP2K3 | 2.15827180 |
| 12 | TBK1 | 2.03663748 |
| 13 | BLK | 1.94807781 |
| 14 | BCKDK | 1.90541016 |
| 15 | SIK1 | 1.90048599 |
| 16 | MAP4K1 | 1.89958422 |
| 17 | TAOK2 | 1.81993850 |
| 18 | MUSK | 1.78364709 |
| 19 | MAP2K6 | 1.61115725 |
| 20 | ARAF | 1.57376135 |
| 21 | ZAK | 1.47583681 |
| 22 | STK16 | 1.47175861 |
| 23 | WNK4 | 1.47142452 |
| 24 | EEF2K | 1.47113553 |
| 25 | IKBKB | 1.40957280 |
| 26 | ICK | 1.38817367 |
| 27 | ABL2 | 1.36998658 |
| 28 | MAPKAPK3 | 1.32738233 |
| 29 | ACVR1B | 1.29609713 |
| 30 | PDPK1 | 1.28397579 |
| 31 | OBSCN | 1.17409980 |
| 32 | MAPK12 | 1.14078359 |
| 33 | PRPF4B | 1.10781105 |
| 34 | SMG1 | 1.09879724 |
| 35 | ADRBK2 | 1.07869411 |
| 36 | MAPK11 | 1.06085391 |
| 37 | SIK2 | 1.05103213 |
| 38 | TAOK1 | 1.03814753 |
| 39 | MAP3K1 | 0.98438618 |
| 40 | TTN | 0.95363659 |
| 41 | TESK1 | 0.92954272 |
| 42 | IRAK2 | 0.92787073 |
| 43 | RPS6KL1 | 0.92302473 |
| 44 | RPS6KC1 | 0.92302473 |
| 45 | PHKG1 | 0.89374765 |
| 46 | PHKG2 | 0.89374765 |
| 47 | GRK6 | 0.88806466 |
| 48 | MAP2K2 | 0.88753730 |
| 49 | GRK7 | 0.86419843 |
| 50 | RPS6KA6 | 0.86189458 |
| 51 | MST1R | 0.85988981 |
| 52 | RPS6KA2 | 0.85271663 |
| 53 | PKN2 | 0.84153997 |
| 54 | MATK | 0.83434814 |
| 55 | MAP3K14 | 0.81179857 |
| 56 | IRAK4 | 0.80044559 |
| 57 | BRAF | 0.75213333 |
| 58 | MAP3K3 | 0.75155526 |
| 59 | IKBKE | 0.73135786 |
| 60 | CDK4 | 0.71825256 |
| 61 | DDR2 | 0.70895856 |
| 62 | ZAP70 | 0.69129822 |
| 63 | DAPK3 | 0.64344802 |
| 64 | PDK1 | 0.62163339 |
| 65 | RPS6KA5 | 0.61732110 |
| 66 | AURKA | 0.60286251 |
| 67 | TYK2 | 0.59603988 |
| 68 | CHUK | 0.58921702 |
| 69 | PINK1 | 0.58836797 |
| 70 | CDC42BPA | 0.58590845 |
| 71 | TNK2 | 0.58565735 |
| 72 | RIPK4 | 0.57282616 |
| 73 | PBK | 0.55400718 |
| 74 | PRKD2 | 0.54073763 |
| 75 | RPS6KB2 | 0.52361904 |
| 76 | CSK | 0.50990316 |
| 77 | CCNB1 | 0.49667176 |
| 78 | AKT2 | 0.44765658 |
| 79 | PRKCI | 0.44583833 |
| 80 | MAP3K13 | 0.44506528 |
| 81 | DAPK1 | 0.44499127 |
| 82 | CAMK2G | 0.44422193 |
| 83 | PRKG2 | 0.44143486 |
| 84 | PRKD1 | 0.44086519 |
| 85 | RIPK1 | 0.43730078 |
| 86 | CAMKK2 | 0.43694596 |
| 87 | SYK | 0.43631699 |
| 88 | BMX | 0.42567511 |
| 89 | PAK1 | 0.42351319 |
| 90 | RPS6KA1 | 0.40686795 |
| 91 | PIM1 | 0.39685262 |
| 92 | CSF1R | 0.39461685 |
| 93 | DAPK2 | 0.39350646 |
| 94 | MAPK4 | 0.38750517 |
| 95 | ILK | 0.38537671 |
| 96 | KDR | 0.38020305 |
| 97 | MTOR | 0.36758926 |
| 98 | PRKD3 | 0.36658271 |
| 99 | EPHA2 | 0.35813442 |
| 100 | DYRK1B | 0.32260327 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sulfur relay system_Homo sapiens_hsa04122 | 4.89583974 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 4.10941276 |
| 3 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 3.37866304 |
| 4 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.24146252 |
| 5 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 3.18931676 |
| 6 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.83217370 |
| 7 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.63397949 |
| 8 | Lysosome_Homo sapiens_hsa04142 | 2.59587792 |
| 9 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.52456103 |
| 10 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.98993053 |
| 11 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.90111584 |
| 12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.83504937 |
| 13 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.75132485 |
| 14 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.50992785 |
| 15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.44290990 |
| 16 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.44004720 |
| 17 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.42399649 |
| 18 | Galactose metabolism_Homo sapiens_hsa00052 | 1.41971280 |
| 19 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.40748138 |
| 20 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.38484995 |
| 21 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.38162567 |
| 22 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.37929370 |
| 23 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.31424342 |
| 24 | Asthma_Homo sapiens_hsa05310 | 1.23152467 |
| 25 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.15945532 |
| 26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.14391615 |
| 27 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.13956212 |
| 28 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.13777336 |
| 29 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.11584540 |
| 30 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.09597906 |
| 31 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.06615441 |
| 32 | Carbon metabolism_Homo sapiens_hsa01200 | 1.06266204 |
| 33 | Allograft rejection_Homo sapiens_hsa05330 | 1.04025799 |
| 34 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.00624055 |
| 35 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.00606090 |
| 36 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.96388331 |
| 37 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.94486640 |
| 38 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.92753076 |
| 39 | Bladder cancer_Homo sapiens_hsa05219 | 0.92671876 |
| 40 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.92322622 |
| 41 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.92224203 |
| 42 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.91710160 |
| 43 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.91509493 |
| 44 | Mineral absorption_Homo sapiens_hsa04978 | 0.89964074 |
| 45 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.89261900 |
| 46 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.86574777 |
| 47 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.85673435 |
| 48 | Tuberculosis_Homo sapiens_hsa05152 | 0.84021165 |
| 49 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.83394665 |
| 50 | Pertussis_Homo sapiens_hsa05133 | 0.82852565 |
| 51 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.80256458 |
| 52 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.79966636 |
| 53 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.79962311 |
| 54 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.78541415 |
| 55 | Leishmaniasis_Homo sapiens_hsa05140 | 0.75504067 |
| 56 | Prion diseases_Homo sapiens_hsa05020 | 0.73545247 |
| 57 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.72757366 |
| 58 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.72549375 |
| 59 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.71633626 |
| 60 | Base excision repair_Homo sapiens_hsa03410 | 0.69794439 |
| 61 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.68366239 |
| 62 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.67747256 |
| 63 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.67452122 |
| 64 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.66777637 |
| 65 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.64449216 |
| 66 | Peroxisome_Homo sapiens_hsa04146 | 0.62591113 |
| 67 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.61728770 |
| 68 | Parkinsons disease_Homo sapiens_hsa05012 | 0.59321807 |
| 69 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.59130853 |
| 70 | Metabolic pathways_Homo sapiens_hsa01100 | 0.58965638 |
| 71 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.57378172 |
| 72 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.56692074 |
| 73 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.56456724 |
| 74 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.55385865 |
| 75 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.55294156 |
| 76 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.55206373 |
| 77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.55088790 |
| 78 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.54217065 |
| 79 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.53359205 |
| 80 | Insulin resistance_Homo sapiens_hsa04931 | 0.52095162 |
| 81 | RNA polymerase_Homo sapiens_hsa03020 | 0.50330624 |
| 82 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.49135663 |
| 83 | Ribosome_Homo sapiens_hsa03010 | 0.45876733 |
| 84 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.45596764 |
| 85 | Hepatitis C_Homo sapiens_hsa05160 | 0.43122624 |
| 86 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.41277614 |
| 87 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.41254510 |
| 88 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.39537253 |
| 89 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.39252945 |
| 90 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.39061059 |
| 91 | Legionellosis_Homo sapiens_hsa05134 | 0.38628321 |
| 92 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.38096844 |
| 93 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.38033576 |
| 94 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.37100313 |
| 95 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.36279199 |
| 96 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.36236257 |
| 97 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.35592403 |
| 98 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.35253625 |
| 99 | Apoptosis_Homo sapiens_hsa04210 | 0.35108197 |
| 100 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.34591091 |

